Clinical Trial
doi: 10.1016/0090-4295(85)90525-4.
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors
- PMID: 3881870
- DOI: 10.1016/0090-4295(85)90525-4
Item in Clipboard
Clinical Trial
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors
Urology.
1985 Feb.
Abstract
Between March, 1978, and July, 1981, 86 patients with polychronotopic superficial papillary bladder tumors and concurrent carcinoma in situ were randomized to receive either transurethral resection alone (43) or TUR plus BCG (43). The results indicate that BCG is not only active in preventing recurrences of new tumors but also effective for the diffuse, flat carcinoma in situ.
Similar articles
-
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder.Cancer. 1983 Apr 1;51(7):1323-6. doi: 10.1002/1097-0142(19830401)51:7<1323::aid-cncr2820510724>3.0.co;2-2. Cancer. 1983. PMID: 6337700 Clinical Trial. No abstract available.
-
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.J Urol. 1986 Feb;135(2):265-7. doi: 10.1016/s0022-5347(17)45604-7. J Urol. 1986. PMID: 3511284 Clinical Trial.
-
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.J Urol. 1992 Apr;147(4):1020-3. doi: 10.1016/s0022-5347(17)37452-9. J Urol. 1992. PMID: 1552578
-
BCG therapy of superficial bladder tumors.Prog Clin Biol Res. 1989;303:369-74. Prog Clin Biol Res. 1989. PMID: 2674999 Review. No abstract available.
-
Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of action.Surg Annu. 1990;22:363-78. Surg Annu. 1990. PMID: 2408170 Review. No abstract available.
Cited by
-
Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.Cochrane Database Syst Rev. 2000;2000(4):CD001986. doi: 10.1002/14651858.CD001986. Cochrane Database Syst Rev. 2000. PMID: 11034738 Free PMC article.
-
Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.BMC Urol. 2020 Jul 8;20(1):91. doi: 10.1186/s12894-020-00642-1. BMC Urol. 2020. PMID: 32641099 Free PMC article.
-
Update on intravesical agents for non-muscle-invasive bladder cancer.Immunotherapy. 2010 May;2(3):381-92. doi: 10.2217/imt.10.1. Immunotherapy. 2010. PMID: 20635902 Free PMC article. Review.
-
Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.World J Urol. 2007 Oct;25(5):525-9. doi: 10.1007/s00345-007-0198-z. Epub 2007 Jul 13. World J Urol. 2007. PMID: 17665201
-
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.Can Urol Assoc J. 2010 Jun;4(3):168-73. doi: 10.5489/cuaj.10051. Can Urol Assoc J. 2010. PMID: 20514279 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
